| 发明名称 |
Diagnosis and treatments relating to HER3 inhibitors |
| 摘要 |
The present application describes the use of NRG1 overexpression as a selection criterion for treating cancer patients with a HER3 inhibitor, such as a bispecific HER3/EGFR inhibitor, and methods of treating those patients. |
| 申请公布号 |
AU2013240261(A1) |
申请公布日期 |
2014.09.18 |
| 申请号 |
AU20130240261 |
申请日期 |
2013.03.15 |
| 申请人 |
GENENTECH, INC. |
发明人 |
AMLER, LUKAS;SHAMES, DAVID |
| 分类号 |
C07K16/28 |
主分类号 |
C07K16/28 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
